AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

📰

Cervical squamous cell carcinoma: the latest breakthroughs

Everything that changed in the last year, from three public sources: phase 3 trials that posted their results, papers in the leading medical and cancer journals, and US drug labels that were updated. Refreshed every week.

🤖

What changed

Written by AI from the evidence below, every point cited

AI reads the results, papers and label updates below and explains what changed and why it matters, citing each source. It is shared with everyone.

🏁

Phase 3 results posted

The large trials that decide new standard treatments · ClinicalTrials.gov
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014).NCT04949256 · results posted 2026-07-20 · Merck Sharp & Dohme LLC · 863 people · tests Pembrolizumab, Lenvatinib, Cisplatin, 5-FU A Study to Investigate Tislelizumab (BGB-A317) Versus Placebo in Combination With Concurrent Chemoradiotherapy in Participants With Localized Esophageal Squamous Cell CarcinomaNCT03957590 · results posted 2026-04-13 · BeiGene · 370 people · tests Tislelizumab, Placebo, Paclitaxel, Cisplatin A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced, Unresectable Recurrent, or Metastatic Esophageal CarcinomaNCT04540211 · results posted 2026-04-09 · Hoffmann-La Roche · 461 people · tests Atezolizumab, Tiragolumab, Paclitaxel, Cisplatin Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION)NCT05386550 · results posted 2026-02-19 · EMD Serono Research & Development Institute, Inc. · 166 people · tests Xevinapant, IMRT, Placebo LUX-Head&Neck 3: Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer After Platinum Based ChemotherapyNCT01856478 · results posted 2026-01-12 · Boehringer Ingelheim · 340 people · tests Methotrexate, Afatinib
📚

In the leading journals

NEJM, Lancet, Nature, JCO, Cancer Cell and more · PubMed
Dalmelitinib Plus Aumolertinib in Advanced NSCLC Patients With EGFR-TKI Resistance and MET Amplification: A Randomized Phase 3 Trial.J Clin Oncol 2026 · PMID 42928710 Wing-tail coordination balances efficient cruising and maneuvering flight in an avian-inspired flapping robot.Nat Commun 2026 · PMID 42928387 Structural dynamics of substrate processing by the p97-Ufd1-Npl4-FAF1 machinery.Nat Commun 2026 · PMID 42928384 Cardiovascular resilience in centenarians.Nat Rev Cardiol 2026 · PMID 42928381 Molecular basis of DNA polymerase ζ's reverse transcriptase activity.Nat Commun 2026 · PMID 42928375 End-to-end design for full-color and large field-of-view computational holographic displays.Nat Commun 2026 · PMID 42928372 Record stack durability in industrial solid oxide steam electrolysis through operational control.Nat Commun 2026 · PMID 42928371 High-sensitivity deep shortwave infrared organic photodetectors enabled by selenium-integrated quinoidal molecular semiconductor.Nat Commun 2026 · PMID 42928368 Electrical signal transmission across electrolyte junctions separated by atomically-thin graphene.Nat Commun 2026 · PMID 42928364 Long-read RNA sequencing identifies non-coding isoform switching as a regulator of cell fate.Nat Commun 2026 · PMID 42928361 Approaching Landauer's limit in a single superconducting vortex memory bit.Nat Commun 2026 · PMID 42928359 Multimodal hydrogel modulation of extracellular vesicle cargo to arrest post-traumatic osteoarthritis in murine models.Nat Commun 2026 · PMID 42928352
🏛️

US drug labels updated

A label changes when a new use, dose or warning is approved · openFDA

No label updates found.

An update is not always a new approval — open the label to see what changed.

Want these every week? Follow cervical squamous cell carcinoma and get a note on your phone with the new trials and papers.

🔔 Follow cervical squamous cell carcinoma
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy